3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sezary Syndrome
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Thyroid Neoplasms
1
Skin Neoplasms
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Lung Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma
1
Bronchiolitis Obliterans Syndrome
1
Breast Neoplasms
1
Interventions
selpercatinib
2
pralsetinib
2
Pemetrexed
2
Carboplatin
2
pembrolizumab
1
durvalumab
1
atezolizumab
1
alectinib
1
Tyrosine Kinase Inhibitors
1
Radiosurgery
1
Paclitaxel
1
Gemcitabine
1
Dasatinib
1
Cisplatin
1
Bevacizumab
1
Afatinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Bronchogenic
×
Interleukin-15
×
Clear all
No trials found.